Larry Schlabach is an expert in the field of Oncology. He attended University of Alabama Medical Center. University of Alabama Medical Center is ranked 37/17 in Research/PrimaryCare. Larry Schlabach is a published doctor. He has 5 publications published. The most current publication "Phase II trial of sorafenib and erlotinib in advanced pancreatic cancer." He accepts Medicare payments and is registered with Medicare.gov.
NPI NUMBER | 1386609394 | |
NPPES Provider LastName | SCHLABACH | |
NPPES Provider FirstName | LARRY | |
NPPES Provider ZIPCode | 374032136 | |
NPPES Provider State | TN | |
Specialty Description | Hematology/Oncology | |
Total Claim Count | 3213.0 | |
Distinct Opioid Count | 9.0 | |
Opioid Claim Count | 388.0 | |
Percent Opioid Claims | 12.08 |
National Provider Identifier [NPI] | 1386609394 |
Last Name Of The Provider | SCHLABACH |
First Name Of The Provider | LARRY |
View All |
Dr. Bennie S. Johnson, MD | |
Dr. Rita R. Claxton, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Davey B. Daniel, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Jitendra Gandhi, MD
This Doctor is OpenDoctor Recommended. This doctor has more publications |
|
Dr. Bertrand M. Anz III, MD | |
Dr. Vaishali Doshi, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. Darrell R. Johnson, MD
This Doctor is OpenDoctor Recommended. |
|
Dr. John McCravey, MD
This Doctor is OpenDoctor Recommended. |